Adverse reactions and tolerability: Since they are administered via injection and affect gastric emptying (particularly in the case of shorter-acting agents), GLP-1 receptor agonists present some tolerability concerns
Semaglutide's gastrointestinal effects vary by product and dose: nausea (20-44%), vomiting (9-24%), and diarrhea (9-30%) according to FDA prescribing information
hdl:10447/463258
The antidiabetic and antioxidant effects of carotenoids: a review
Other common side effects of GLP-1 agonists: diarrhea or constipation abdominal pain belching, gas, or heartburn feeling bloated injection site reactions vomiting Your clinician will offer you tips for managing side effects , as well as share common contraindications (reasons to not take semaglutide), including a personal or family history of medullary thyroid cancer or multiple endocrine neoplasia
Find it on Apple Podcasts, Spotify, or wherever you get your podcasts